Vancouver, Wash. biotech company Absci files to go public
GeekWire
JUNE 30, 2021
based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built to design and generate protein-based drug candidates and help screen them for optimal functioning. The company took in $1.1 Net losses were $14.4
Let's personalize your content